|
"perng rp"的相關文件
顯示項目 16-58 / 58 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2007-05 |
Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy
|
Chen, YM;Liu, JM;Chou, TY;Perng, RP;Tsai, CM;Whang-Peng, J |
| 國家衛生研究院 |
2007-03 |
Effect of age on pulmonary metastases and immunotherapy in young and middle-aged mice
|
Chen, YM;Wang, PS;Liu, JM;Hsieh, YL;Tsai, CM;Perng, RP;Whang-Peng, J |
| 高雄醫學大學 |
2007 |
Hormone replacement therapy;lung cancer risk in Chinese.
|
黃明賢; Chen KY;Hsiao CF;Chang GC;Tsai YH;Su WC;Perng RP;Huang MS;Hsiung CA;Chen CJ;Yang PC;GEFLAC Study Group |
| 國家衛生研究院 |
2006-07 |
Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-06 |
A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
|
Chen, YM; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-04 |
A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy
|
Chen, YM; Shih, JF; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-02 |
A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly
|
Chen, YM; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-01 |
Leukotriene C-4 induces TGF-beta(1) production in airway epithelium via p38 kinase pathway
|
Perng, DW;Wu, YC;Chang, KT;Wu, MT;Chiou, YC;Su, KC;Perng, RP;Lee, YC |
| 高雄醫學大學 |
2006 |
Double-blind r;omized parallel group study comparing the efficacy;safety of tiotropium;ipratropium in the treatment of COPD patients in Taiwan.
|
黃明賢; Hsu JY;Perng RP;Lu JY;Wu CP;Huang MS;Luh KT;Yang PC. |
| 國家衛生研究院 |
2005-07 |
Chemotherapy for non-small cell lung cancer in elderly patients
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2005-06 |
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer
|
Tsai, CM;Chiu, CH;Chou, TY;Li, LH;Hsiao, CY;Chen, M;Perng, RP;Tsai, SF |
| 國家衛生研究院 |
2005-06 |
A phase II trial of UFUR plus gemcitabine in non-small cell lung cancer patients failing previous platinum-based chemotherapy
|
Chen, YM;Perng, RP;Tsai, CM;Whang-Peng, J |
| 國家衛生研究院 |
2005-05-15 |
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer
|
Chou, TY; Chiu, CH; Li, LH; Hsiao, CY; Tzen, CY; Chang, KT; Chen, YM; Perng, RP; Tsai, SF; Tsai, CM |
| 國家衛生研究院 |
2005-03 |
A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2004-07 |
Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms
|
Chen, YM; Perng, RP; Chu, H; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2004-07 |
Preliminary report of a randomized trial of different docetaxel schedules in non-small cell lung cancer patients failing previous chemotherapy
|
Chen, YM;Shih, JF;Tsai, CM;Perng, RP;Whang-Peng, J |
| 國家衛生研究院 |
2004-02-26 |
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Shih, JF; Lee, YC; Lee, CS; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2003-12 |
Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy
|
Chen, YM; Perng, RP; Lee, CS; Lin, WC; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2003-05 |
A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older
|
Chen, YM; Perng, RP; Chen, MC; Tsai, CM; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
2003-02 |
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel
|
Chen, YM; Shih, JF; Lee, CS; Chen, MC; Lin, WC; Tsai, CM; Perng, RP |
| 國家衛生研究院 |
2002-10 |
Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
|
Chen, YM; Perng, RP; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2002-10 |
Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes
|
Chen, YM; Tsai, CM; Whang-Peng, J; Perng, RP |
| 國家衛生研究院 |
2002-02 |
Additive effect of interleukin-12 and interleukin-18 on the T-helper cell pathway of malignant pleural effusion
|
Yao, NS; Chen, YM; Perng, RP; Whang-Peng, J |
| 國家衛生研究院 |
2002-01 |
Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Lee, YC; Shih, JF; Lee, CS; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2001-04 |
Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: Comparison of malignant and tuberculous pleural effusions
|
Chen, YM; Tsai, CM; Whang-Peng, J; Perng, RP |
| 國家衛生研究院 |
2001-01 |
An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer
|
Chen, YM; Yang, WK; Whang-Peng, J; Tsai, CM; Perng, RP |
| 臺北醫學大學 |
2001 |
Childhood tuberculosis presenting as an anterior chest wall abscess
|
黃群耀; Huang CY; Su WJ; Perng RP; |
| 臺北醫學大學 |
2001 |
Utility of PCR assays for rapid diagnosis of BCG infection in children
|
黃群耀; Su WJ; Huang CY; Perng RP; |
| 國家衛生研究院 |
2000-12 |
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
|
Chen, YM; Perng, RP; Whang-Peng, J; Wu, HW; Lin, WC; Tsai, CM |
| 國家衛生研究院 |
2000-09 |
Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer
|
Wang, PC; Yang, KY; Chao, JY; Liu, JM; Perng, RP; Yen, SH |
| 國家衛生研究院 |
2000-08 |
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2000-06 |
A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Liu, TW; Tsai, CM; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer
|
Perng, RP; Shih, JF; Chen, YM; Delgado, FM; Tsai, CM; Chou, KC; Liu, JM; Chern, MS; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Liu, JM; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2000-01 |
Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: Interleukin-15 vs. interleukin-2
|
Chen, YM; Ting, CC; Peng, JW; Yang, WK; Yang, KY; Tsai, CM; Perng, RP |
| 國家衛生研究院 |
2000 |
Phase II study of docetaxel plus gemcitabine in patients with non-small cell lung cancer (NSCLC) that failed previous chemotherapy (CT)
|
Chen, YM;Perng, RP;Whang-Peng, J;Lin, WC;Wu, HW;Tsai, CM |
| 國家衛生研究院 |
1999-09 |
A multi-centre phase II trial of gemcitabine (GEM) and vinorelbine (VRL) in patients (PTS) with stage III-IV non small cell lung cancer (NSCLC)
|
Chen, YM;Perng, RP;Peng, JW;Liu, TW;Yang, KY;Lin, WC;Wu, HW;Shih, JF;Liu, JM;Chen, LT;Tsai, CM |
| 國家衛生研究院 |
1998-03 |
Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions
|
Perng, RP; Chen, YM; Wu, MF; Chou, KC; Lin, WC; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
1997-10 |
Cross regulation by IL-10 and 1L-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients
|
Chen, YM; Yang, WK; Ting, CC; Tsai, WY; Yang, DM; WhangPeng, J; Perng, RP |
| 國家衛生研究院 |
1997-09 |
Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients
|
Chen, YM; Yang, WK; WhangPeng, J; Tsai, WY; Hung, YM; Yang, DM; Lin, WC; Perng, RP; Ting, CC |
| 國家衛生研究院 |
1997-07 |
A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions
|
Perng, RP;Wu, MF;Lin, SY;Chen, YM;Lin, JY;WhangPeng, J |
| 國家衛生研究院 |
1997-05 |
Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study
|
Perng, RP; Chen, YM; MingLiu, J; Tsai, CM; Lin, WC; Yang, KY; WhangPeng, J |
| 國家衛生研究院 |
1997-04 |
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer
|
Chen, YM;Wu, MF;Perng, RP;Chou, CM;Yang, KY;Lin, WC;Tsai, CM;Liu, JM;WhangPeng, J |
顯示項目 16-58 / 58 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
